Association of Serum Zinc Level with severity of chronic kidney disease in diabetic patients: a cross-sectional study

被引:8
作者
Kubota, Mitsunobu [1 ]
Matsuda, Shizuka
Matsuda, Mimu
Yamamoto, Kazuki
Yoshii, Yoko
机构
[1] Natl Hosp Org Kure Med Ctr, Dept Endocrinol & Diabet, 3-1 Aoyamacho, Kure, Hiroshima 7370023, Japan
关键词
Serum zinc concentration; Diabetic nephropathy; Diabetic kidney disease; Chronic kidney disease; Estimated glomerular filtration rate; Albuminuria; MICROALBUMINURIA; SUPPLEMENTATION; PREVALENCE; NEPHROPATHY; CHOLESTEROL; MANAGEMENT; HEALTH; RISK;
D O I
10.1186/s12882-022-03040-x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In recent years, it has been reported that diabetic patients tend to have a lower zinc intake due to unbalanced diet accompanying changes in lifestyle habits. We investigated serum zinc concentration in diabetic patients according to the stage of nephropathy.Methods: We enrolled 227 diabetic patients (119 men, 108 women, average age 65.7 +/- 14.7 [mean +/- standard deviation]) who were hospitalized for diabetes treatment due to poor blood glucose control. We investigated the relationship between fasting serum zinc concentration and estimated glomerular filtration rate (eGFR) and albuminuria (urinary albumin-to-creatinine ratio, UACR), as well as serum zinc concentration by stage of diabetic kidney disease and chronic kidney disease.Results: The mean HbA1c value was 10.5 +/- 2.1%. Serum zinc concentration was 75.5 +/- 16.0 mu g/dL in males and 75.7 +/- 12.2 mu g/dL in females, showing no gender difference and no significant relationship with diabetes type. The serum zinc concentration was negatively correlated with age (r= - 0.309, P < 0.001) and positively correlated with eGFR (r = 0.144, P = 0.030). A tendency was observed of serum zinc concentration to decrease after overt nephropathy, with values of 76.4 +/- 14.1 mu g/dL in pre-nephropathy (stage 1, n = 131), 78.5 +/- 13.2 mu g/dL in incipient nephropathy (stage 2, n = 65), 66.4 +/- 14.3 mu g/dL in overt nephropathy (stage 3, n = 25), and 65.7 +/- 11.9 mu g/dL in kidney failure (stage 4, n = 6). Serum zinc showed a negative trend with estimated GFR (P = 0.004) and significant reduction in albuminuria, with stage A3 (n = 29, 65.7 +/- 13.9 mu g/dL) having lower levels than A1 (n = 131, 76.4 +/- 14.1 mu g/dL, P = 0.001) and A2 (n = 67, 78.4 +/- 13.1 mu g/dL, P < 0.001).Conclusions: In diabetic patients, serum zinc concentration tended to decrease as age increased and also as renal function deteriorated. This study suggests that consideration of zinc deficiency is necessary in patients with overt albuminuria.
引用
收藏
页数:8
相关论文
共 49 条
[1]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]   Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease' [J].
Andrassy, Konrad M. .
KIDNEY INTERNATIONAL, 2013, 84 (03) :622-623
[3]   Improving nutrition through biofortification: A review of evidence from HarvestPlus, 2003 through 2016 [J].
Bouis, Howarth E. ;
Saltzman, Amy .
GLOBAL FOOD SECURITY-AGRICULTURE POLICY ECONOMICS AND ENVIRONMENT, 2017, 12 :49-58
[4]   URINARY ZINC AND ITS RELATIONSHIPS WITH MICROALBUMINURIA IN TYPE-I DIABETICS [J].
BRUN, JF ;
FONS, C ;
FUSSELLIER, M ;
BARDET, L ;
ORSETTI, A .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1992, 32 :317-323
[5]   Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment [J].
Chen, Liang-Kung ;
Woo, Jean ;
Assantachai, Prasert ;
Auyeung, Tung-Wai ;
Chou, Ming-Yueh ;
Iijima, Katsuya ;
Jang, Hak Chul ;
Kang, Lin ;
Kim, Miji ;
Kim, Sunyoung ;
Kojima, Taro ;
Kuzuya, Masafumi ;
Lee, Jenny S. W. ;
Lee, Sang Yoon ;
Lee, Wei-Ju ;
Lee, Yunhwan ;
Liang, Chih-Kuang ;
Lim, Jae-Young ;
Lim, Wee Shiong ;
Peng, Li-Ning ;
Sugimoto, Ken ;
Tanaka, Tomoki ;
Won, Chang Won ;
Yamada, Minoru ;
Zhang, Teimei ;
Akishita, Masahiro ;
Arai, Hidenori .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) :300-+
[6]   The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients [J].
Chevalier, CA ;
Liepa, G ;
Murphy, MD ;
Suneson, J ;
VanBeber, AD ;
Gorman, MA ;
Cochran, C .
JOURNAL OF RENAL NUTRITION, 2002, 12 (03) :183-189
[7]  
Classen Hans-Georg, 2011, Med Monatsschr Pharm, V34, P87
[8]   Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline [J].
Damianaki, Katerina ;
Lourenco, Joao Miguel ;
Braconnier, Philippe ;
Ghobril, Jean-Pierre ;
Devuyst, Olivier ;
Burnier, Michel ;
Lenglet, Sebastien ;
Augsburger, Marc ;
Thomas, Aurelien ;
Pruijm, Menno .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (07) :1163-1170
[9]   The status of zinc in type 2 diabetic patients and its association with glycemic control [J].
Farooq, Dhedhi M. ;
Alamri, Ali F. ;
Alwhahabi, Basmah K. ;
Metwally, Ashraf M. ;
Kareem, Khalid A. .
JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2020, 27 (01) :29-36
[10]   Relationships of the Trace Elements Zinc and Magnesium With Diabetic Nephropathy-Associated Renal Functional Damage in Patients With Type 2 Diabetes Mellitus [J].
Feng, Jianan ;
Wang, Heyuan ;
Jing, Zhe ;
Wang, Yue ;
Wang, Wanning ;
Jiang, Yanfang ;
Sun, Weixia .
FRONTIERS IN MEDICINE, 2021, 8